Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Medinger

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 14, 2013
Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)Andreas Pircher, Michael Fiegl, Gerold Untergasser, et al.
BMC Cancer|July 12, 2014
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysisKlaus Mross, Martin Büchert, Annette Frost, et al.
Cancer Genomics & Proteomics|July 2, 2016
Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel AgentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
British Journal of Clinical Pharmacology|November 22, 2016
Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicityFelix Hammann, Verena Gotta, Katrin Conen, et al.
Anticancer Research|July 28, 2004
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapyJoachim Drevs, Julia Fakler, Silke Eisele, et al.
Bone Marrow Transplantation|April 1, 2022
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantationClaire Seydoux, Raphael Battegay, Joerg Halter, et al.
Leukemia & Lymphoma|October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Leukemia Research|April 24, 2017
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaMichael Medinger, Deborah Zeiter, Dominik Heim, et al.
Thrombosis Research|December 7, 2013
Dkk3 levels in patients with myeloproliferative neoplasmsMichael Medinger, Patricia Muesser, Sabine Girsberger, et al.
Journal of Clinical Apheresis|March 13, 2012
Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion centerJoerg-Peter Sigle, Michael Medinger, Martin Stern, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|May 14, 2013
Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)Andreas Pircher, Michael Fiegl, Gerold Untergasser, et al.
BMC Cancer|July 12, 2014
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysisKlaus Mross, Martin Büchert, Annette Frost, et al.
Cancer Genomics & Proteomics|July 2, 2016
Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel AgentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
British Journal of Clinical Pharmacology|November 22, 2016
Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicityFelix Hammann, Verena Gotta, Katrin Conen, et al.
Anticancer Research|July 28, 2004
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapyJoachim Drevs, Julia Fakler, Silke Eisele, et al.
Bone Marrow Transplantation|April 1, 2022
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantationClaire Seydoux, Raphael Battegay, Joerg Halter, et al.
Leukemia & Lymphoma|October 14, 2016
Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)Chantal Fridle, Michael Medinger, Matthias C Wilk, et al.
Leukemia Research|April 24, 2017
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaMichael Medinger, Deborah Zeiter, Dominik Heim, et al.
Thrombosis Research|December 7, 2013
Dkk3 levels in patients with myeloproliferative neoplasmsMichael Medinger, Patricia Muesser, Sabine Girsberger, et al.
Journal of Clinical Apheresis|March 13, 2012
Prospective change control analysis of transfer of platelet concentrate production from a specialized stem cell transplantation unit to a blood transfusion centerJoerg-Peter Sigle, Michael Medinger, Martin Stern, et al.
Pageof 9